Abstract
OBJECTIVE: To determine the number of different radiation schedules used in Ontario to treat women with node-negative breast cancer after lumpectomy and axillary dissection. DESIGN: Retrospective survey. SETTING: Princess Margaret Hospital, Toronto, and regional centres of the Ontario Cancer Treatment and Research Foundation (in Hamilton, London, Ottawa, Windsor and Thunder Bay). PATIENTS: A total of 551 of 1624 consecutive patients with node-negative breast cancer having undergone lumpectomy and axillary dissection who were eligible but did not participate in the Ontario Clinical Oncology Group randomized clinical trial and who received adjuvant breast irradiation between April 1984 and February 1989. OUTCOME MEASURES: Schedules of radiotherapy received. RESULTS: Forty-eight different radiotherapy schedules were identified. Total doses ranged from 4000 to 6600 cGy and the number of fractions from 15 to 30. Several different schedules were preferred: 322 patients (58.5%) received 4000 cGy in 15 or 16 fractions to the whole breast over 3 weeks plus a local boost of 1250 cGy to the primary site in 5 fractions over 1 week; 66 patients (12.0%) received 4000 cGy in 15 or 16 fractions over 3 weeks to the whole breast plus a local boost of 1000 cGy to the primary site in 4 or 5 fractions over 1 week; and 63 patients (11.5%) received 5000 cGy in 25 fractions to the whole breast in 5 weeks, without a boost. CONCLUSIONS: The practice of adjuvant radiotherapy for early breast cancer in Ontario varies. The optimal radiation regimen for patients after lumpectomy should be determined through randomized clinical trials.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Clark R. M., McCulloch P. B., Levine M. N., Lipa M., Wilkinson R. H., Mahoney L. J., Basrur V. R., Nair B. D., McDermot R. S., Wong C. S. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst. 1992 May 6;84(9):683–689. doi: 10.1093/jnci/84.9.683. [DOI] [PubMed] [Google Scholar]
- Clark R. M., Wilkinson R. H., Mahoney L. J., Reid J. G., MacDonald W. D. Breast cancer: a 21 year experience with conservative surgery and radiation. Int J Radiat Oncol Biol Phys. 1982 Jun;8(6):967–979. doi: 10.1016/0360-3016(82)90163-8. [DOI] [PubMed] [Google Scholar]
- Denham J. W., Sillar R. W., Clarke D. Boost dosage to the excision site following conservative surgery for breast cancer: it's easy to miss! Clin Oncol (R Coll Radiol) 1991 Sep;3(5):257–261. doi: 10.1016/s0936-6555(05)80873-8. [DOI] [PubMed] [Google Scholar]
- Fisher B., Bauer M., Margolese R., Poisson R., Pilch Y., Redmond C., Fisher E., Wolmark N., Deutsch M., Montague E. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 1985 Mar 14;312(11):665–673. doi: 10.1056/NEJM198503143121101. [DOI] [PubMed] [Google Scholar]
- Fisher B., Redmond C., Poisson R., Margolese R., Wolmark N., Wickerham L., Fisher E., Deutsch M., Caplan R., Pilch Y. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989 Mar 30;320(13):822–828. doi: 10.1056/NEJM198903303201302. [DOI] [PubMed] [Google Scholar]
- Fowler J. F. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989 Aug;62(740):679–694. doi: 10.1259/0007-1285-62-740-679. [DOI] [PubMed] [Google Scholar]
- Langlois D. Enquete sur les modalités des traitements conservant le sein dans les centres anticancéreux. Bull Cancer. 1990;77(8):793–797. [PubMed] [Google Scholar]
- Priestman T. J., Bullimore J. A., Godden T. P., Deutsch G. P. The Royal College of Radiologists' Fractionation Survey. Clin Oncol (R Coll Radiol) 1989 Sep;1(1):39–46. doi: 10.1016/s0936-6555(89)80010-x. [DOI] [PubMed] [Google Scholar]
- Ribeiro G. G., Dunn G., Swindell R., Harris M., Banerjee S. S. Conservation of the breast using two different radiotherapy techniques: interim report of a clinical trial. Clin Oncol (R Coll Radiol) 1990 Jan;2(1):27–34. doi: 10.1016/s0936-6555(05)80215-8. [DOI] [PubMed] [Google Scholar]
- Sarrazin D., Lê M., Rouëssé J., Contesso G., Petit J. Y., Lacour J., Viguier J., Hill C. Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less. The experience of the Institut Gustave-Roussy. Cancer. 1984 Mar 1;53(5):1209–1213. doi: 10.1002/1097-0142(19840301)53:5<1209::aid-cncr2820530531>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
- Trott K. R., Kummermehr J. Rapid repopulation in radiotherapy: a debate on mechanism. Accelerated repopulation in tumours and normal tissues. Radiother Oncol. 1991 Nov;22(3):159–160. doi: 10.1016/0167-8140(91)90018-c. [DOI] [PubMed] [Google Scholar]
- Veronesi U., Saccozzi R., Del Vecchio M., Banfi A., Clemente C., De Lena M., Gallus G., Greco M., Luini A., Marubini E. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med. 1981 Jul 2;305(1):6–11. doi: 10.1056/NEJM198107023050102. [DOI] [PubMed] [Google Scholar]
- Withers H. R., Taylor J. M., Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988;27(2):131–146. doi: 10.3109/02841868809090333. [DOI] [PubMed] [Google Scholar]